# Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

> **NCT00930644** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 88 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** teduglutide

## Key facts

- **NCT ID:** NCT00930644
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-21
- **Primary completion:** 2013-01-24
- **Final completion:** 2013-01-24
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2021-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00930644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00930644, "Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00930644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*